Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Dr. Moss has generously offered to continue these Q&A sessions to keep us informed. Please feel free to submit additional questions by email to cfri@cfri.org. This most recent session was recorded on May 6, 2020.
We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.